09.04.2020
It's Not Business As Usual
It's Not Business As Usual
In this 2 part series, Psyma's Oncology Practice Lead, Gordon Gochenauer, shared his thoughts in anticipation of the ASCO 2018 conference, particularly on the anticipated keynotes in immuno-oncology for non-small cell lung cancer, as well the future of immunotherapy combinations based on recent IDO trials results to be presented at ASCO 2018.
PART 1:
PART 2:
09.04.2020
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.Mehr erfahren Video laden YouTube immer entsperren ... more
05.02.2019
Gordon Gochenauer, Oncology Practice Leader at Psyma, discusses oncology pipeline management and asset prioritization in the immuno-oncology era through a multi-step approach combining market research ... more